Barely Significant
← all excerpts

Evaluation of Consistency of Treatment Response Across Regions-the LEADER Trial in Relation to the ICH E17 Guideline.

Front Med (Lausanne) · 2021 · PMC8201994 · PMID 34136501

Europe PMCDOI
2
hedged sentences
0.0490
closest p · 1.0× alpha
0.0500
boldest claim

The sentences

nominally significantp = 0.049actually significant
non-US subgroups was nominally significant ( p = 0.049), although this result was not corrected for multiple comparisons.

also in 7,732 other papers

marginally significantp = 0.05actually significant
A marginally significant interaction ( p = 0.05) was detected for this region.

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.